Výsledky vyhľadávania - "Tadolini, M."

Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts Autor Motta, I., Centis, R., D’Ambrosio, L., García-García, J.-M., Goletti, D., Gualano, G., Lipani, F., Palmieri, F., Sánchez-Montalvá, A., Pontali, E., Sotgiu, G., Spanevello, A., Stochino, C., Tabernero, E., Tadolini, M., van den Boom, M., Villa, S., Visca, D., Migliori, G.B.

“…Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB…”
Získať plný text

National TB prevalence surveys in the COVID-19 era Autor Tadolini, M, Onozaki, I

Zistit podrobnosti o prístupe

Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019 Autor Matji, R., Maama, L., Roscigno, G., Lerotholi, M., Agonafir, M., Sekibira, R., Law, I., Tadolini, M., Kak, N.

“…The Kingdom of Lesotho has one of the highest burdens of tuberculosis (TB) in the world. A national TB prevalence survey was conducted to estimate the…”
Získať plný text

We cannot eliminate TB without TB drugs: a wake-up call from Italy Autor Sotgiu, G, Riccardi, N, De Francisci, S, Tadolini, M

Zistit podrobnosti o prístupe

Clinical standards for the dosing and management of TB drugs Autor Alffenaar, J W C, Stocker, S L, Forsman, L Davies, Garcia-Prats, A, Heysell, S K, Aarnoutse, R E, Akkerman, O W, Aleksa, A, van Altena, R, de Oñata, W Arrazola, Bhavani, P K, Van't Boveneind-Vrubleuskaya, N, Carvalho, A C C, Centis, R, Chakaya, J M, Cirillo, D M, Cho, J G, D Ambrosio, L, Dalcolmo, M P, Denti, P, Dheda, K, Fox, G J, Hesseling, A C, Kim, H Y, Köser, C U, Marais, B J, Margineanu, I, Märtson, A G, Torrico, M Munoz, Nataprawira, H M, Ong, C W M, Otto-Knapp, R, Peloquin, C A, Silva, D R, Ruslami, R, Santoso, P, Savic, R M, Singla, R, Svensson, E M, Skrahina, A, van Soolingen, D, Srivastava, S, Tadolini, M, Tiberi, S, Thomas, T A, Udwadia, Z F, Vu, D H, Zhang, W, Mpagama, S G, Schön, T, Migliori, G B

“…Optimal drug dosing is important to ensure adequate response to treatment, prevent development of drug resistance and reduce drug toxicity. The aim of these…”
Zistit podrobnosti o prístupe

TB consilia and quality of tuberculosis management Autor Pontali, E, Tadolini, M, Migliori, G B

Zistit podrobnosti o prístupe

Ten common myths about drug-susceptible TB Autor Riccardi, N, Antonello, R M, Besozzi, G, Tadolini, M, Codecasa, L

Zistit podrobnosti o prístupe

TB mortality in low-incidence countries: can we reduce it further? Autor Granozzi, B, Bisognin, F, Lombardi, G, Dal Monte, P, Tadolini, M

Zistit podrobnosti o prístupe

IGRA test for TB in COVID-19: role of corticosteroids Autor Granozzi, B, Bisognin, F, Tadolini, M, Lombardi, G, Zangoli, E, Salvi, D, Dormi, A, Dal Monte, P

Zistit podrobnosti o prístupe

Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine Autor Calcagno, A., Coppola, N., Sarmati, L., Tadolini, M., Parrella, R., Matteelli, A., Riccardi, N., Trezzi, M., Di Biagio, A., Pirriatore, V., Russo, A., Gualano, G., Pontali, E., Surace, L., Falbo, E., Mencarini, J., Palmieri, F., Gori, A., Schiuma, M., Lapadula, G., Goletti, D.

“…Background Non-tuberculous mycobacteria (NTM) are generally free-living organism, widely distributed in the environment, with sporadic potential to infect. In…”
Získať plný text

Clinical standards for drug-susceptible pulmonary TB Autor Akkerman, O W, Duarte, R, Tiberi, S, Schaaf, H S, Lange, C, Alffenaar, J W C, Denholm, J, Carvalho, A C C, Bolhuis, M S, Borisov, S, Bruchfeld, J, Cabibbe, A M, Caminero, J A, Carvalho, I, Chakaya, J, Centis, R, Dalcomo, M P, D Ambrosio, L, Dedicoat, M, Dheda, K, Dooley, K E, Furin, J, García-García, J-M, van Hest, N A H, de Jong, B C, Kurhasani, X, Märtson, A G, Mpagama, S, Torrico, M Munoz, Nunes, E, Ong, C W M, Palmero, D J, Ruslami, R, Saktiawati, A M I, Semuto, C, Silva, D R, Singla, R, Solovic, I, Srivastava, S, de Steenwinkel, J E M, Story, A, Sturkenboom, M G G, Tadolini, M, Udwadia, Z F, Verhage, A R, Zellweger, J P, Migliori, G B

“…The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB). A…”
Zistit podrobnosti o prístupe

The first population-based national tuberculosis prevalence survey in Ethiopia, 2010-2011 Autor Kebede, A H, Alebachew, Z, Tsegaye, F, Lemma, E, Abebe, A, Agonafir, M, Kebede, A J, Demissie, D, Girmachew, F, Yaregal, Z, Dana, F, Getahun, M, Fiseha, Y, Meaza, A, Dirse, N, Timimi, H, Sismanidis, C, Tadolini, M, Onozaki, I

“…Tuberculosis (TB) remains a major public health problem in Ethiopia. To determine the prevalence of pulmonary TB among the general adult population aged ≥15…”
Zistit podrobnosti o prístupe

National population-based tuberculosis prevalence survey in Ghana, 2013 Autor Bonsu, F, Addo, K K, Alebachew, Z, Gyapong, J, Badu-Peprah, A, Gockah, R, Hanson-Nortey, N N, Law, I, Tadolini, M, Onozaki, I, Sismanidis, C, Owusu-Dabo, E

“…The prevalence of tuberculosis (TB) disease is one of the three main indicators used to assess the epidemiological burden of TB and the impact change of TB…”
Zistit podrobnosti o prístupe

A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care Autor Vanino, E, Tadolini, M, Attard, L, Cascavilla, A, Pea, F, Viale, P

Zistit podrobnosti o prístupe

TB outpatient care in a high-income, low-incidence country Autor Riccardi, N, Monari, C, Antonello, R M, Saderi, L, Occhineri, S, Pontarelli, A, Zucchi, P, Buonsenso, D, Falbo, E, Faverio, P, Aliberti, S, Parrella, R, Falcone, M, Besozzi, G, Calcagno, A, Goletti, D, Gualano, G, Sotgiu, G, Tadolini, M, Codecasa, L

Zistit podrobnosti o prístupe

Vaccination in post-tuberculosis lung disease management: A review of the evidence Autor Nasiri, M.J., Silva, D.R., Rommasi, F., Zahmatkesh, M.M., Tajabadi, Z., Khelghati, F., Sarmastzadeh, T., Centis, R., D'Ambrosio, L., Bombarda, S., Dalcolmo, M.P., Galvão, T., de Queiroz Mello, F.C., Rabahi, M.F., Pontali, E., Solovic, I., Tadolini, M., Marconi, L., Tiberi, S., van den Boom, M., Sotgiu, G., Migliori, G.B.

“…Post-tuberculosis lung disease (PTLD), as other chronic respiratory disorders, may have infectious complications; some of them can be prevented with…”
Získať plný text

Spinal tuberculosis: proposed spinal infection multidisciplinary management project (SIMP) flow chart revision Autor Vanino, E, Tadolini, M, Evangelisti, G, Zamparini, E, Attard, L, Scolz, K, Terzi, S, Barbanti Brodano, G, Girolami, M, Pipola, V, Gasbarrini, A, Viale, P

“…We propose a revised flow chart of spinal infection multidisciplinary management project (SIMP) aimed to standardize the diagnostic process and management of…”
Zistit podrobnosti o prístupe

Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond Autor D’Ambrosio, L, Bothamley, G, Caminero Luna, J.A, Duarte, R, Guglielmetti, L, Muñoz Torrico, M, Payen, M.C, Saavedra Herrera, N, Salazar Lezama, M.A, Skrahina, A, Tadolini, M, Tiberi, S, Veziris, N, Migliori, G.B

“…AbstractAs recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known…”
Získať plný text

Human herpesvirus‐8‐related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin Autor Verucchi, G., Calza, L., Trevisani, F., Zambruni, A., Tadolini, M., Giuliani, R., Manfredi, R., Andreone, P., Chiodo, F., Bernardi, M.

“…: The iatrogenic form of Kaposi's sarcoma (KS) is typically observed among transplant recipients, and the most appropriate therapeutic approach (usually…”
Získať plný text

Clinical standards for the management of adverse effects during treatment for TB Autor Singh, K P, Carvalho, A C C, Centis, R, D Ambrosio, L, Migliori, G B, Mpagama, S G, Nguyen, B C, Aarnoutse, R E, Aleksa, A, van Altena, R, Bhavani, P K, Bolhuis, M S, Borisov, S, van T Boveneind-Vrubleuskaya, N, Bruchfeld, J, Caminero, J A, Carvalho, I, Cho, J G, Davies Forsman, L, Dedicoat, M, Dheda, K, Dooley, K, Furin, J, García-García, J M, Garcia-Prats, A, Hesseling, A C, Heysell, S K, Hu, Y, Kim, H Y, Manga, S, Marais, B J, Margineanu, I, Märtson, A-G, Munoz Torrico, M, Nataprawira, H M, Nunes, E, Ong, C W M, Otto-Knapp, R, Palmero, D J, Peloquin, C A, Rendon, A, Rossato Silva, D, Ruslami, R, Saktiawati, A M I, Santoso, P, Schaaf, H S, Seaworth, B, Simonsson, U S H, Singla, R, Skrahina, A, Solovic, I, Srivastava, S, Stocker, S L, Sturkenboom, M G G, Svensson, E M, Tadolini, M, Thomas, T A, Tiberi, S, Trubiano, J, Udwadia, Z F, Verhage, A R, Vu, D H, Akkerman, O W, Alffenaar, J W C, Denholm, J T

“…Adverse effects (AE) to TB treatment cause morbidity, mortality and treatment interruption. The aim of these clinical standards is to encourage best practise…”
Zistit podrobnosti o prístupe